Multimedia Update: FDA Grants Accelerated Approval for Immunomedics’ Trodelvy in Previously-Treated Metastatic Triple-Negative Breast Cancer
23 avr. 2020 08h00 HE
|
Immunomedics, Inc.
First FDA-approved antibody-drug conjugate that targets the Trop-2 antigen Trodelvy is the first antibody-drug conjugate approved by FDA specifically for the treatment of relapsed or refractory...
Biotheranostics Announces Chief Commercial Officer
01 avr. 2020 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, April 01, 2020 (GLOBE NEWSWIRE) -- On April 1, 2020, company veteran and Vice President of Sales, Matt Sargent, was promoted to the position of Chief Commercial Officer. In this...
Todos Medical Announces Publication Demonstrating Potential of FTIR Platform to Identify Bacterial and Viral Infections
02 mars 2020 08h50 HE
|
Todos Medical Ltd.
Todos evaluating applying its proprietary FTIR platform towards the novel coronavirusSeeking appropriate partners to get access to patient samples to train its AI platform REHOVOT, Israel and NEW...
Breast Cancer Conference Brings Young Survivors Together
27 févr. 2020 12h53 HE
|
Young Survival Coalition
Los Angeles, CA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Young Survival Coalition (YSC) brings its fifth annual conference to Los Angeles, California, March 6-8, 2020, where it will host more than 600...
Young Survival Coalition Welcomes New Board Leadership and Members
27 févr. 2020 12h45 HE
|
Young Survival Coalition
New York, NY, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Young Survival Coalition (YSC) announces new leadership for its Board of Directors. Desirée A.H. Walker, President, and John Hennessy, Vice President,...
Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing
25 févr. 2020 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Biotheranostics’ Pivotal Clinical Study of the Breast Cancer Index® featured on the cover of the Annals of Oncology
24 févr. 2020 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- A pivotal clinical study validating Breast Cancer Index earns the distinction of being selected for the cover of the Annals of Oncology. The...
Todos Medical Receives Notice of Allowance from European Patent Office Covering Diagnosis of Solid Tumors Using AI to Analyze Blood
19 févr. 2020 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Releases Letter to Shareholders
07 févr. 2020 09h15 HE
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes
09 janv. 2020 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...